AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 10 USDMF, 4 CEP/COS, 9 JDMF, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

121 FDF Dossiers, 11 FDA Orange Book, 13 Europe, 2 Canada, 25 South Africa, 70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 5 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 2 Bioplus Life Sciences, 8 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 11 Kerry, 3 Lonza Capsugel, 2 Lubrizol Life Science Health, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 23 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 28 Thickeners and Stabilizers, 26 Coating Systems & Additives, 22 Topical, 20 Solubilizers, 17 Direct Compression, 17 Lubricants & Glidants, 17 Disintegrants & Superdisintegrants, 15 Controlled & Modified Release, 15 Parenteral, 13 Taste Masking, 12 Co-Processed Excipients, 12 Film Formers & Plasticizers, 12 Granulation, 9 Emulsifying Agents, 8 Empty Capsules, 6 Chewable & Orodispersible Aids, 3 Rheology Modifiers, 3 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 6 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 Regulatory FDF Prices

6 Regulatory FDF Prices

MARKET PLACE

34 APIs, 3 EXCIPIENTS

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 5 JP

ANALYTICAL

7 Analytical Methods

7 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
30/12/2024	Active Pharma	Japan	Active Pharma Inc.	226MF10192	Tocopherol Nicotinate	2014-09-30	2014-09-30	2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
30/12/2024	Patheon	U.S.A	Patheon Austria GmbH & Co KG	222MF10047	Neostigmine methylsulfate	2010-02-09	2016-06-17	St. -Peter-Strasse 25, 4020 Linz / Austria

(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol

(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

10 USDMF

4 CEP/COS

9 JDMF

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

121 FDF Dossiers

11 FDA Orange Book

13 Europe

2 Canada

25 South Africa

70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

5 SPI Pharma

7 DKSH

1 Pharm-RX Chemical

5 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

9 Actylis

1 Aeon Procare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

15 BASF

2 Bioplus Life Sciences

8 Corel Pharma Chem

3 DFE Pharma

2 Finar

10 Gangwal Chemicals

3 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

11 Kerry

3 Lonza Capsugel

2 Lubrizol Life Science Health

9 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qualicaps

23 Roquette

7 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders

28 Thickeners and Stabilizers

26 Coating Systems & Additives

22 Topical

20 Solubilizers

17 Direct Compression

17 Lubricants & Glidants

17 Disintegrants & Superdisintegrants

15 Controlled & Modified Release

15 Parenteral

13 Taste Masking

12 Co-Processed Excipients

12 Film Formers & Plasticizers

12 Granulation